U.S. flag

An official website of the United States government

NM_000143.4(FH):c.1256C>T (p.Ser419Leu) AND Hereditary cancer-predisposing syndrome

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Feb 18, 2016
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000494270.9

Allele description [Variation Report for NM_000143.4(FH):c.1256C>T (p.Ser419Leu)]

NM_000143.4(FH):c.1256C>T (p.Ser419Leu)

Gene:
FH:fumarate hydratase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1q43
Genomic location:
Preferred name:
NM_000143.4(FH):c.1256C>T (p.Ser419Leu)
HGVS:
  • NC_000001.11:g.241500571G>A
  • NG_012338.1:g.24184C>T
  • NM_000143.4:c.1256C>TMANE SELECT
  • NP_000134.2:p.Ser419Leu
  • NP_000134.2:p.Ser419Leu
  • LRG_504t1:c.1256C>T
  • LRG_504:g.24184C>T
  • LRG_504p1:p.Ser419Leu
  • NC_000001.10:g.241663871G>A
  • NM_000143.3:c.1256C>T
Protein change:
S419L
Links:
dbSNP: rs1131691244
NCBI 1000 Genomes Browser:
rs1131691244
Molecular consequence:
  • NM_000143.4:c.1256C>T - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000581666Ambry Genetics
criteria provided, single submitter

(Ambry General Variant Classification Scheme_2022)
Likely pathogenic
(Feb 18, 2016)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknown1not providednot provided1not providedclinical testing

Details of each submission

From Ambry Genetics, SCV000581666.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testingnot provided

Description

The p.S419L variant (also known as c.1256C>T), located in coding exon 9 of the FH gene, results from a C to T substitution at nucleotide position 1256. The serine at codon 419 is replaced by leucine, an amino acid with dissimilar properties. This variant was not reported in population based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), NHLBI Exome Sequencing Project (ESP), and 1000 Genomes Project. In the ESP, this variant was not observed in 6503 samples (13006 alleles) with coverage at this position. To date, this alteration has been detected with an allele frequency of approximately 0.01% (greater than 10000 alleles tested) in our clinical cohort. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. While this specific alteration has not been reported in the literature to date, another alteration at the same codon, p.S419P (designated as S376P), segregated with disease in one HLRCC family in the literature (Wei, MH et al. J Med Genet. 2006 Jan;43(1):18-27). Based on the majority of available evidence to date, the p.S419L variant is likely to be pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknown1not providednot provided1not providednot providednot provided

Last Updated: Apr 15, 2024